PRTX-100

DRUG3 trials

Sponsors

Protalex, Inc.

Conditions

Arthritis, RheumatoidImmune Thrombocytopenia

Phase 1

6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection

CompletedNCT02330445

Protalex, Inc.Arthritis, Rheumatoid

Start: 2015-02-28End: 2016-11-30Updated: 2018-10-16

PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP

TerminatedNCT02401061

Protalex, Inc.Immune Thrombocytopenia

Start: 2015-09-30End: 2019-06-04Updated: 2019-07-05

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

TerminatedNCT02566603

Protalex, Inc.Immune Thrombocytopenia

Start: 2015-11-30End: 2018-05-17Updated: 2019-03-25